Misson and Values

Novassay is developing novel leads tools in the Ion Channel Biology arena and pursues R&D targeting specific indications.

Our own drug development programs focus in Neurodegenartive diseases to include Chronic Neuropathic Pain, Alzheimer’s, Parkinson’s and Multiple sclerosis as well as in Oncology (solid and hematological malignancies). Until now company’s assets were created and developed in house however we still consider licensing-in new assets focused in Onco-Channelopathies.